The amyloid proteins isolated from neuritic plaques and the cerebrovasculature of Alzheimer's disease are self-aggregating moieties termed A4 protein and beta-protein, respectively. A putative A4 amyloid precursor (herein termed A4(695] has been characterized by analysis of a human brain complementary DNA. We report here the sequence of a closely related amyloid cDNA, A4(751), distinguished from A4(695) by the presence of a 168 base-pair (bp) sequence which adds 57 amino acids to, and removes one residue from, the predicted A4(695) protein. The peptide predicted from this insert is very similar to the Kunitz family of serine proteinase inhibitors. The two A4-specific messenger RNAs are differentially expressed: in a limited survey, A4(751) mRNA appears to be ubiquitous, whereas A4(695) mRNA has a restricted pattern of expression which includes cells from neuronal tissue. These data may have significant implications for understanding amyloid deposition in Alzheimer's disease.
Tunnelling is one of the key features of quantum mechanics. A related debate, ongoing since the inception of quantum theory, is about the value, meaning and interpretation of 'tunnelling time' 1-5 . Simply put, the question is whether a tunnelling quantum particle spends a finite and measurable time under a potential barrier. Until recently the debate was purely theoretical, with the process considered to be instantaneous for all practical purposes. This changed with the development of ultrafast lasers and attosecond metrology 6 , which gave physicists experimental access to the attosecond (1 as = 10 -18 s) domain. It is at this time scale
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.